Clinical Trials Sponsored by SpeeDx Pty. Ltd.

Total 915 results

Saluda Medical Pty Ltd

Recruiting

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain (Freshwater)

Chronic Pain

Australia
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
GlaxoSmithKline
Iqvia Pty Ltd

Completed

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 6)

Multiple Myeloma

United States, Australia, Spain, United Kingdom, Canada
AstraZeneca
Iqvia Pty Ltd

Active, not recruiting

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (MEDIOLA)

SCLC | Breast | Ovarian | Gastric Cancers

United Kingdom, United States, Korea, Republic of, France, Netherlands, Israel, Switzerland
Oticara Australia PTY LTD

Terminated

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream (OT-007)

Chronic Rhinosinusitis (Diagnosis)

Australia
AstraZeneca
Iqvia Pty Ltd

Completed

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. (PROVENT)

COVID-19

United States, Belgium, France, Spain, United Kingdom
StimAire Australia Pty Ltd

Terminated

StimAire Sleep Study

Obstructive Sleep Apnea

Australia
Atmo Biosciences Pty Ltd

Active, not recruiting

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Gastroparesis | IBS | Slow Transit Constipation

United States
GlaxoSmithKline
Iqvia Pty Ltd

Terminated

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) (contRAst 2)

Arthritis, Rheumatoid

United States, Australia, Germany, Japan, Korea, Republic of, Poland, Bulgaria, Estonia, Hungary, Mexico, Russian Federation, Spain, Thailand, Colombia, China, Argentina, United Kingdom, France
RDC Clinical Pty Ltd

Withdrawn

Effect of Fenugreek Fibre on Gut Microbiome

Gut Microbiome

Australia
RDC Clinical Pty Ltd

Completed

The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema

Eczema, Atopic

Australia
RDC Clinical Pty Ltd

Completed

A Study to Determine Optimal Absorption of Single Dose Omega-3

Optimal Gastrointestinal Absorption of Omega-3

Australia
GlaxoSmithKline
Iqvia Pty Ltd

Completed

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors (contRAst 3)

Arthritis, Rheumatoid

United States, Germany, Canada, Czechia, Poland, South Africa, Korea, Republic of, Spain, Japan, Argentina, Belgium, Hungary, United Kingdom, Italy, Lithuania
ENA Respiratory Pty Ltd

Completed

INNA-051 Influenza Challenge Study

Influenza Prophylaxis

United Kingdom
Cinnagen
Vaxine Pty Ltd

Completed

Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Covid19

Iran, Islamic Republic of
Max Biocare Pty. Ltd.

Completed

Tregocel® as a Dietary Supplement in Mild Knee Osteoarthritis

Mild Knee Osteoarthritis

Poland
Waterstone Hanxbio Pty Ltd

Active, not recruiting

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

China
Telix International Pty Ltd

Completed

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC (ZIRDAC-JP)

Carcinoma, Renal Cell | Clear Cell Renal Cell Carcinoma

Japan
AstraZeneca
Iqvia Pty Ltd

Terminated

Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease (HESTIA3)

Sickle Cell Disease

Italy, Spain, United Kingdom, Belgium, United States, India, South Africa, Brazil, Turkey, Egypt, Ghana, Greece, Kenya, Lebanon, Tanzania, Uganda
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 XG005-03 Topical Study

Pain

Australia
HighTide Biopharma Pty Ltd

Withdrawn

A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

Adolescent | Digestive System Diseases | Biliary Tract Diseases | Primary Sclerosing Cholangitis | Cholangitis | Cholangitis, Sclerosing | Bile Duct Diseases
HighTide Biopharma Pty Ltd

Completed

Study of HTD4010 in Healthy Volunteers

Type 2 Diabetes Mellitus

Australia
HighTide Biopharma Pty Ltd

Completed

A Study of HTD1801 in Healthy Subjects

Primary Sclerosing Cholangitis

Australia
Admedus Regen Pty Ltd.

Completed

CardioCel Tri-leaflet Repair Study (CTRS)

Aortic Stenosis | Aortic Insufficiency

Belgium
Zai Lab Pty. Ltd.

Unknown

Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis

Australia
Janssen-Cilag Pty Ltd

Completed

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

HIV-1

United States, Australia
Janssen-Cilag Pty Ltd

Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

HIV-1

Australia
Janssen-Cilag Pty Ltd

Completed

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

Schizophrenia

Australia
Janssen-Cilag Pty Ltd

Completed

Schizophrenia Treatment Adherence Investigation (STAI)

Schizophrenia | Schizoaffective Disorder
Janssen-Cilag Pty Ltd

Completed

Prospective Research in Memory Clinics (PRIME)

Dementia | Mild Cognitive Impairment

Australia
Janssen-Cilag Pty Ltd

Completed

Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

Kidney Transplantation | Transplantation
Universal Biosensors Pty Ltd

Unknown

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

Blood Coagulation Disorders

United States
Auzone Biological Technology Pty Ltd
TIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd

Completed

A Study of TTYP01 in Healthy Adult Subjects

Healthy Adult Subjects

Australia
RDC Clinical Pty Ltd

Not yet recruiting

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

Knee Joint Pain

Australia
Kangabio AUSTRALIA LTD PTY

Not yet recruiting

A Phase 1, First-in-Human of KGX101 to Patients With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Australia
AJNA Australia Pty Ltd

Not yet recruiting

A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects

Healthy Volunteers
RDC Clinical Pty Ltd

Not yet recruiting

Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

Iron-deficiency

Australia
Ikaria Bioscience Pty Ltd

Recruiting

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other Comorbidities

Australia
Oticara Australia PTY LTD

Recruiting

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients With Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Chronic Rhinosinusitis (Diagnosis)

Australia
GLYCAR SA (Pty) Ltd

Recruiting

GLYCAR Post Market Multicenter Study (CIP002)

Congenital Premature Cardiac Closure | Cardiac and Great Vessel Reconstruction and Repair | Peripheral Vascular Reconstruction and Repair

France
Prokidney
Iqvia Pty Ltd

Not yet recruiting

A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease

Chronic Kidney Diseases | Type 2 Diabetes Mellitus
Waterstone Hanxbio Pty Ltd

Recruiting

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

Relapsed/Refractory Lymphoma

China
Atmo Biosciences Pty Ltd

Recruiting

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

Small Intestinal Bacterial Overgrowth

Australia, India
GlaxoSmithKline
Iqvia Pty Ltd

Recruiting

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE)

Asthma

United States, Australia, Austria, Canada, Finland, France, Germany, Ireland, Italy, Japan, Netherlands, Norway, Puerto Rico, Slovenia, Spain, Sweden, Switzerland, Taiwan, United Kingdom, Israel, Portugal
AstraZeneca
Iqvia Pty Ltd

Active, not recruiting

A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab (JUBILUS)

Respiratory Syncytial Virus Infections

Japan
argenx
Iqvia Pty Ltd

Completed

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS (POTS)

Postural Orthostatic Tachycardia Syndrome

United States
AstraZeneca
Iqvia Pty Ltd

Terminated

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) (ARROYO)

Chronic Spontaneous Urticaria

United States, Germany, Korea, Republic of, Spain, Bulgaria, Poland, Japan
PolyNovo Biomaterials Pty Ltd.

Terminated

Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers (DFUs)

Diabetic Foot | Foot Ulcer | Wound Healing | Chronic Foot Ulcer

United States
Telix International Pty Ltd

Completed

177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study (ProstACTSelect)

Metastatic Prostate Cancer

Australia
GlaxoSmithKline
Iqvia Pty Ltd

Terminated

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) (contRAst X)

Arthritis, Rheumatoid

United States, Germany, Japan, Korea, Republic of, Poland, Ukraine, Bulgaria, Canada, Czechia, Estonia, Hungary, Mexico, Russian Federation, South Africa, Spain, Malaysia, Thailand, China, Argentina, Belgium, India, United Kingdom, ... and more

Clinical Trials Sponsored by SpeeDx Pty. Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations